Parkinson Disease Clinical Trials in Aurora, Colorado

7 studies are recruiting for parkinson disease in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Site-025, Aurora, Colorado
    Locations
    22 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT06976268 on ClinicalTrials.gov

  2. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    University of Colorado - Anschutz Medical Campus, Aurora, Colorado
    Locations
    72 in total
    Run by
    Neuron23 Inc.

    See if you can join NCT06680830 on ClinicalTrials.gov

  3. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT04477785 on ClinicalTrials.gov

  4. Use of CereGate Therapy for Freezing of Gait in PD

    A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.

    Stage
    Not phased
    Ages
    21 to 80
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Locations
    7 in total
    Run by
    CereGate Inc.

    See if you can join NCT05292794 on ClinicalTrials.gov

  5. Neocortical Microarchitecture of Executive Function

    This study is being done to the determine the ability and utility of using the Neuropixels probes in the human brain. A Neuropixels probe will be inserted into and removed from the brain of awake human patients who are undergoing awake Deep Brain Stimulation (DBS) surgery.

    Stage
    Not phased
    Ages
    45 to 85
    Site
    University of Colorado, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT06778135 on ClinicalTrials.gov

  6. Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease

    The cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and rigidity. Though non-motor features have been recognized for centuries, only recently has the prevalence and impact of non-motor symptoms become the focus of intense study. Disturbances of sleep are among…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT05348837 on ClinicalTrials.gov

  7. Adaptive DBS to Offset STN Dysregulation During Exercise in PD

    The investigators conduct a prospective study to evaluate the effects of exercise on Parkinson's Disease brain biomarkers detected with the PerceptTM PC neurostimulator.

    Stage
    Not phased
    Ages
    20 to 70
    Site
    University of Colorado, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT06296810 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.